Journal of Neurology Neurosurgery & Psychiatry (J NEUROL NEUROSUR PS )
Journal of Neurology, Neurosurgery, & Psychiatry (JNNP) publishes important papers covering the whole field of clinical neurological practice. Emphasis is given to common disorders such as cerebrovascular disease, multiple sclerosis, Parkinson's disease, peripheral neuropathy, epilepsy, subarachnoid haemorrhage, including papers concerning pathogenesis and treatment. Only high priority articles are published in the journal.
- Impact factor4.92Show impact factor historyHide impact factor history
- 5-year impact5.14
- Cited half-life0.00
- Immediacy index1.69
- Article influence1.82
- WebsiteJournal of Neurology, Neurosurgery & Psychiatry website
- Other titlesJournal of neurology, neurosurgery and psychiatry, Journal of neurology, neurosurgery & psychiatry
- Material typePeriodical, Internet resource
- Document typeJournal / Magazine / Newspaper, Internet Resource
- Author can archive a pre-print version
- Author cannot archive a post-print version
- 6 months embargo
- On author or institutional server only
- Publisher copyright and source must be acknowledged
- Must link to publisher version
- Publisher's version/PDF cannot be used
- Accepted version may be placed on PubMed Central and mirror sites after 12 months from publication
- Classification yellow
Publications in this journal
Article: Genetic counselling in ALS: facts, uncertainties and clinical suggestions. Chiò A, Battistini S, Calvo A, Caponnetto C, Conforti FL, Corbo M, Giannini F, Mandrioli J, Mora G, Sabatelli M; the ITALSGEN Consortium,, Ajmone C, Mastro E, Pain D, Mandich P, Penco S, Restagno G, Zollino M, Surbone A. J Neurol Neurosurg Psychiatry. 2013 Jul 6. [Epub ahead of print][show abstract] [hide abstract]
ABSTRACT: The clinical approach to patients with amyotrophic lateral sclerosis (ALS) has been largely modified by the identification of novel genes, the detection of gene mutations in apparently sporadic patients, and the discovery of the strict genetic and clinical relation between ALS and frontotemporal dementia (FTD). As a consequence, clinicians are increasingly facing the dilemma on how to handle genetic counselling and testing both for ALS patients and their relatives. On the basis of existing literature on genetics of ALS and of other late-onset life-threatening disorders, we propose clinical suggestions to enable neurologists to provide optimal clinical and genetic counselling to patients and families. Genetic testing should be offered to ALS patients who have a first-degree or second-degree relative with ALS, FTD or both, and should be discussed with, but not offered to, all other ALS patients, with special emphasis on its major uncertainties. Presently, genetic testing should not be proposed to asymptomatic at-risk subjects, unless they request it or are enrolled in research programmes. Genetic counselling in ALS should take into account the uncertainties about the pathogenicity and penetrance of some genetic mutations; the possible presence of mutations of different genes in the same individual; the poor genotypic/phenotypic correlation in most ALS genes; and the phenotypic pleiotropy of some genes. Though psychological, social and ethical implications of genetic testing are still relatively unexplored in ALS, we recommend multidisciplinary counselling that addresses all relevant issues, including disclosure of tests results to family members and the risk for genetic discrimination.Journal of Neurology Neurosurgery & Psychiatry 07/2013;
- Journal of Neurology Neurosurgery & Psychiatry 01/2013;
Article: mazza sJournal of Neurology Neurosurgery & Psychiatry 01/2011;
- Journal of Neurology Neurosurgery & Psychiatry 01/2010;
- Journal of Neurology Neurosurgery & Psychiatry 01/2009; 80(1).
Article: DURELLI L., BARBERO P., BERGUI M., VERSINO E., BASSANO M.A., VERDUN E., RIVOIRO C., FERRERO C., PICCO E., RIPELLINO P., GIULIANI G., MONTANARI E., CLERICO M.; Italian Multiple Sclerosis Study Group: MRI activity and neutralising antibody as predictors of response to interferon beta treatment in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry: 79, 646-651, 2008Journal of Neurology Neurosurgery & Psychiatry 01/2008; 79:646-651.
- Journal of Neurology Neurosurgery & Psychiatry 01/2007; 78(2):207-207.
- JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY; 01/2007
- Journal of Neurology Neurosurgery & Psychiatry 06/2006; 77(5):639.
- Journal of Neurology Neurosurgery & Psychiatry 06/2006; 77(5):569.
- Journal of Neurology Neurosurgery & Psychiatry 06/2006; 77(5):707-8.
- [show abstract] [hide abstract]
ABSTRACT: We report the case of a middle aged Tanzanian man who developed a spinal cord syndrome over 6 weeks, along with a mild encephalopathy. Investigations ruled out the usual major causes of such a syndrome in our setting in northern Tanzania. Examination of his cerebrospinal fluid revealed trypanosomes, and he made a slow but dramatic improvement after a full course of suramine and melarsoprol. We postulate that he had a transverse myelitis due to African trypanosomiasis, a rare and barely recognised cause.Journal of Neurology Neurosurgery & Psychiatry 06/2006; 77(5):684-5.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.
ISSN: 1878-5883, Impact factor: 2.32
Clinical neurophysiology: official journal of the International Federation of Clinical Neurophysiolo...
ISSN: 1872-8952, Impact factor: 3.12
Institution Acta Ophthalmologica...
ISSN: 1755-3768, Impact factor: 2.44
International Society for Microbial...
ISSN: 1751-7370, Impact factor: 8.95
Cambridge University Press
ISSN: 1748-5460, Impact factor: 0.68
United States. Alcohol, Drug Abuse,...
ISSN: 1745-1701, Impact factor: 8.8
ISSN: 1741-2854, Impact factor: 1.15